The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

21 Mar 2011 07:00

RNS Number : 2659D
Ultima Networks PLC
21 March 2011
 



Embargoed for release at 7am 21 March 2011

 

Ultima Networks plc

('Ultima' or the 'Company')

 

Trading update

 

 

Ultima, the IT and Green Technology company, is pleased to provide an update on trading in advance of the release of its results for the year ended 31 December 2010.

 

Ultima is please to announce that full year revenues and net profit have increased over the prior year. The Board expects to report turnover to be broadly in line with market expectations with net profit being materially ahead of market expectations.

 

Ultima's IT Services division, Cognito Software, has continued to grow through increased sales of its range of software products and services. Following the launch of "FiLos", Cognito's new legal software suite, Ultima has seen an increased level of interest in Cognito's product offering particularly from the larger legal practices. The sales, support and marketing budget for Cognito during 2011 has been increased with the view to accelerating the organic growth of the division primarily through increased penetration of FiLos in the legal services marketplace. The Board is also continuing to evaluate potential acquisitions which would assist the growth of the division. The IT Services division provides recurring revenue for Ultima and is benefiting from a strong management team.

 

The Company's Green technology products division experienced difficult market conditions in the first half of 2010, as announced by Ultima on 19 August 2010. The Board of Ultima is pleased to however report that the second half of the year has seen an improved trading performance and, as previously announced, Ultima has in the second half of the year received major new orders for its mainland European version of the Infineum electric bicycle. The level of these orders has exceeded management expectations. The Board remain confident that volumes for the 2011 calendar year will reach the division's targets of 2,500 units. The bicycle is being marketed by the division's Dutch distributor, EQ-Bikes.

 

Ultima's Green power division, which is focused on the development of clean power generation through solar power parks in Spain and Italy, continued to develop its solar energy credentials in 2010. In November 2010 Ultima successfully commissioned and connected the Company's 100KW solar park in Spain to the Spanish National Grid. This is expected to make a small contribution to Ultima's revenue in 2011. In Italy discussions are continuing with ENEL Spa to finalise details for the connection to the Italian high voltage grid however no connection date has yet been given by ENEL and Ultima are currently considering alternative options to generate value from their Italian solar power project. The Board remain in discussions with potential parties who are interested in providing debt funding to support the construction of the proposed three 1MW Solar Parks planned for Puglia. Delays in connection of the proposed 3 x 1 MW parks will lead to a reduction in the feed-in tariff however the Board expects this to be offset by reductions in the capital cost of the projects. The Green power division has also recently launched a Solar PV Initative Scheme for UK based Schools which is designed to provide solar installations to participating schools free of cost. The Green power division will receive the government backed feed-in tariff which is index linked and guaranteed to be paid for a period of 25 years.

 

Ultima anticipates releasing its results for the year ended 31 December 2010 on 23rd May 2011.

 

 

Ultima Networks plc

Prof. Humayun Mughal, Chairman and CEO

Tel: 01279 821 200

Allenby Capital Limited

(Nominated Adviser and Broker)

Tel: +44 (0)203 328 5656

Nick Naylor

Nick Athanas

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFIFWAFFSEDD
Date   Source Headline
29th Apr 202410:59 amRNSPosting of Annual Report & Notice of AGM
26th Apr 20247:00 amRNSN4 Pharma Webinar on SRI Collaboration
25th Apr 20247:38 amRNSCollaboration Agreement with SRI International Inc
23rd Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSOral Delivery Update
4th Mar 20243:13 pmRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSin-vitro siRNA update
19th Jan 20247:00 amRNSPatent Grant
18th Jan 202410:15 amRNSHolding(s) in Company
16th Jan 20247:00 amRNSNanogenics Update
8th Jan 20244:24 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSAAV Viral Vector Update
18th Dec 20237:00 amRNSOral Delivery Update
7th Dec 202311:28 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSNuvec® R&D and Strategy Update
30th Nov 20239:00 amRNSN4 Pharma Launches New Interactive Investor Hub
31st Oct 20237:00 amRNSTotal Voting Rights
9th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 20238:15 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSInvestor Presentation
28th Sep 20237:00 amRNSAcquisition of Controlling Interest in Nanogenics
12th Sep 20237:00 amRNSInterim Results
25th Jul 20237:00 amRNSPatent Grant and Board Change
27th Jun 20237:00 amRNSGrant Award for Professor Chengzhong Yu
25th Apr 20237:00 amRNSsiRNA update
18th Apr 20237:00 amRNSsiRNA update
3rd Apr 20232:11 pmRNSResult of AGM
9th Mar 20237:00 amRNSPosting of Annual Report & Notice of AGM
9th Mar 20237:00 amRNSFinal Results
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20232:05 pmRNSSecond Price Monitoring Extn
17th Jan 20232:00 pmRNSPrice Monitoring Extension
17th Jan 202311:05 amRNSSecond Price Monitoring Extn
17th Jan 202311:00 amRNSPrice Monitoring Extension
17th Jan 20239:05 amRNSSecond Price Monitoring Extn
17th Jan 20239:00 amRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSOral application update
30th Nov 20225:28 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20222:49 pmRNSHolding(s) in Company
22nd Nov 202210:50 amRNSResult of Broker Offer and Total Voting Rights
18th Nov 20227:01 amRNSBroker Offer to raise a maximum of £1 million
18th Nov 20227:00 amRNSPlacing to raise £1million and Broker Offer
1st Nov 20227:00 amRNSPatent filing update
4th Oct 20227:00 amRNSDouble siRNA Testing Update
29th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSOperational Update
15th Jul 20227:00 amRNSWork Programme Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.